Dr Christopher R. McHenry (Cleveland, OH): You defined tertiary hyperparathyroidism as a PTH of >72. As you
know, most of these patients can have very, very marked elevation in their PTH levels.
I wondered, of your total patients with tertiary hyperparathyroidism, do you have
any information, then, on what percentage of these patients resolved with additional
time beyond your 9-month period? You said that only 6% or such actually were operated
on, but of those patients that were not operated on, was there a subset of patients
that went on to eventually resolve their tertiary hyperparathyroidism? My second question
is, in your abstract, you talked about a 12% long-term recurrence rate. I wondered,
what was the cause for the recurrence? Was this remnant hyperplasia? Was this owing
to supernumerary glands? How did you deal with these patients that had recurrence?
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Published online: October 22, 2015
Identification
Copyright
© 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
